PDI Combing Urology, Neurology Markets For Licensing/Acquisition Deals
Executive Summary
PDI is aiming to build a "long-term portfolio" of specialty products through licensing deals, beginning in the urology and neurology markets
You may also be interested in...
PDI Rx Licensing Strategy Puts CSO In Competition With Small Manufacturers
PDI's breach of contract settlement with Auxilium is a result of the contract sales organization's new strategy of competing with small pharmaceutical manufacturers
PDI Evista Lessons Learned: Firm Focuses On Smaller Contracts, No Baselines
PDI will focus on smaller contract sales opportunities in the 50-representative range following termination of the Evista promotion deal with Lilly, CEO Charles Saldarini said on a conference call Nov. 12
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011